PCMA Applauds Judiciary Committee on Passage of CREATES Act to Help Lower Drug Prices
June 14, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on the Senate Judiciary Committee’s...
PCMA Statement on HELP Committee Hearing on President’s Blueprint to Lower Drug Prices
June 12, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the Health, Education, Labor and Pensions Committee...
Federal Circuit Court Unanimously Strikes Down Arkansas Mandate Restricting PBM Tools
June 08, 2018
(Washington, D.C.) — The Eighth Circuit Court of Appeals, in a unanimous three judge decision, today ruled in favor of the...
PCMA Statement on New OIG Medicare Part D Report
June 04, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on a Medicare Part D report released today...
May 29, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Congressional Budget Office’s (CBO) $43...
PCMA Statement on New Avalere Study Examining Generic Drugs in Medicare
May 22, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement today on a new Avalere study, Generic...
PCMA Statement on the Administration’s Blueprint to Lower Drug Prices
May 11, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Administration’s new Blueprint on drug...
PCMA: American Diabetes Association White Paper Confirms Drugmakers Set and Raise Insulin Prices
May 08, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement regarding a white paper released today by the American...
PCMA President and CEO Mark Merritt to Depart At Year-End
May 07, 2018
(Washington, D.C.) — After 15 years at the helm of the Pharmaceutical Care Management Association (PCMA), CEO and President Mark...
PCMA Response to FDA Commissioner’s Comments on Brand Drugmaker Pricing & Rebates
May 03, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today following remarks by Food and Drug...
New Illinois Medicaid Mandate Gives “Blank Check” to Independent Drugstores
April 30, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on Illinois HB 3479: “Employers, unions, and...
Illinois Legislation Protects Drug Manufacturer High Prices, Reduces Competition
April 26, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association released the following statement on Illinois legislation, HB 4146: “This bill would force the...